Anti-CD19 FasT CAR-T Cell Therapy for B Cell NHL

NCT04638270 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma, Non-Hodgkin

Interventions

BIOLOGICAL: anti-CD19 FasT CAR-T cells

Sponsor

Xinqiao Hospital of Chongqing

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]